HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

polidocanol (Laureth)

Subscribe to New Research on polidocanol

polyethylene glycol monododecyl ether (average polymer n=9); RN in Chemline for nonaethyleneglycol monododecyl ether: 3055-99-0

Also Known As:

Laureth; aethoxysclerol; aethoxysklerol; aetoxisclerol; atossisclerol; atoxysclerol; ethoxysclerol; hydroxypolyethoxydodecane; laureth-9; lubrol 12A9; lubrol-PX; nonaethyleneglycol monododecyl ether; polyoxyethylene 9-lauryl ether; polyoxyethylene lauryl ether; polyoxyethylenedodecyl ether; thesit; alpha-dodecyl-omega-hydroxypoly(oxy-1,2ethanediyl)

Networked: 349 relevant articles (50 outcomes, 54 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1.	Alfredson, Håkan: 13 articles (04/2011 - 07/2004)
2.	Ohberg, Lars: 9 articles (09/2008 - 06/2002)
3.	Cabrera, Juan: 5 articles (10/2009 - 11/2003)
4.	Redondo, Pedro: 5 articles (10/2009 - 11/2003)
5.	Itou, Chihiro: 3 articles (09/2015 - 07/2012)
6.	Koizumi, Jun: 3 articles (09/2015 - 07/2012)
7.	Myojin, Kazunori: 3 articles (09/2015 - 07/2012)
8.	Hashimoto, Takeshi: 3 articles (09/2015 - 07/2012)
9.	Kagawa, Tatehiro: 3 articles (09/2015 - 07/2012)
10.	Altmeyer, Peter: 3 articles (01/2013 - 11/2006)

Related Diseases

1.	Hemorrhage 06/01/2007 - "The efficacy of hemostasis with Polidocanol and Tetradecyl Sulfate has been evaluated through the comparison of perioperative bleeding amount and preoperative and postoperative hematocrit levels in the 24th hour. " 08/01/2015 - "Polidocanol injection decreases the bleeding rate after colon polypectomy: a propensity score analysis." 03/14/2011 - "The combined therapy of hemoclip hemostasis with aethoxysklerol injection is the most effective method for gastrointestinal bleeding due to Dieulafoy's lesion." 06/01/2007 - "Upon comparison of perioperative bleeding amounts: the Control Group values were very high in comparison to the Polidocanol group (p < 0.001) and the Tetradecyl Sulfate group values were higher than those of the Polidocanol group (p < 0.05). " 06/01/2007 - "Perioperative bleeding amounts were: 1.50 +/- 0.20 mL in the Polidocanol group, 3.50 +/- 0.15 mL in the Tetradecyl Sulfate group and 7.50 +/- 0.41 mL in the Control Group. "
2.	Varicose Veins (Varicose Vein) 04/10/1990 - "Varices were injected with ethoxysclerol 1% in weekly sessions if possible until they were completely eradicated. " 06/01/2012 - "Efficacy and safety of Aethoxysklerol® (polidocanol) 0.5%, 1% and 3% in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study)." 12/01/2015 - "Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance." 08/03/2015 - "Polidocanol (Varithena) for varicose veins." 10/01/2014 - "Polidocanol endovenous microfoam provided clinically meaningful benefit in treating symptoms and appearance in patients with varicose veins. "
3.	Sclerosis 11/01/2003 - "Sclerosis therapy with polidocanol microfoam was judged beneficial in 46 (92%) of the 50 patients. " 01/01/2014 - "Direct puncture and sclerosis with polidocanol foam are an effective treatment for LFVM of the face and oral cavity." 09/01/2002 - "Sonographically guided percutaneous injection of 1% polidocanol for sclerosis of peripheral vascular lesions is simple, effective, and safe. " 12/01/2011 - "To report the efficacy of percutaneous puncture and sclerosis using polidocanol in the treatment of venous malformations (VMs) in pediatric patients. " 03/01/2011 - "The efficacy of sclerosis was reported in total occlusion of 46 sites (92.0%) in foam therapy and of 38 sites (76.0%) in Polidocanol liquid therapy after 90 days. "
4.	Esophageal and Gastric Varices (Esophageal Varices) 12/01/2012 - "Variant treatment for gastric varices with polidocanol foam using balloon-occluded retrograde transvenous obliteration: a pilot study." 07/01/2012 - "Twenty consecutively registered patients with gastric varices underwent balloon-occluded retrograde transvenous obliteration with polidocanol foam. " 04/01/1990 - "[Mechanism of action, indications and problems in using aethoxysklerol as a sclerosing agent in esophageal varices]." 12/01/1988 - "Effect of low dosage of polidocanol in treatment of esophageal varices in cirrhotic patients." 01/01/1983 - "[Experiences with fiber endoscopy sclerosing of esophageal varices with polidocanol]."
5.	Tendinopathy (Tendonitis) 06/01/2008 - "That is a drawback, since this is the area targeted in promising treatment regimens of chronic painful patellar tendinosis, namely sclerosing Polidocanol injection therapy, and a new surgical method conforming to ultrasound and color Doppler guided arthroscopic shaving, directed at neovessels found in the region. " 03/01/2009 - "Doppler ultrasound-guided polidocanol sclerosant injection treating bilateral quadriceps tendinopathy." 09/01/2008 - "Fifty-two consecutive Achilles tendons (48 patients, mean age 49.6 years) with chronic painful midportion Achilles tendinopathy, were randomised to treatment with Polidocanol 5 mg/ml (group A) or 10 mg/ml (group B). " 11/01/2006 - "To investigate sclerosing treatment using polidocanol on a group of elite athletes with patellar tendinopathy. " 11/01/2006 - "Sclerosing the area with vascular ingrowth using polidocanol has shown promising clinical results in patients with Achilles tendinopathy. "

Related Drugs and Biologics

1.	Sclerosing Solutions (Sclerosing Agents)
2.	Epinephrine (Adrenaline)
3.	polidocanol (Laureth)
4.	Fibrin Tissue Adhesive (Fibrin Sealant)
5.	Ethanol (Ethyl Alcohol)
6.	ethanolamine oleate (Ethamolin)
7.	Sodium
8.	Yttrium
9.	Cyanoacrylates
10.	Glucose (Dextrose)

Related Therapies and Procedures

1.	Sclerotherapy
2.	Injections
3.	Solid-State Lasers
4.	Lasers (Laser)
5.	Intra-Arterial Injections